Corsi Minerva Kolesar

References to studies included in this review Allie EC, Kane MP, Busch RS, Bakst G, Hamilton RA. Orlistat in Obese Patients with Type 2 Diabetes A Retrospective Assessment of Weight Loss and Metabolic Effects. Hospital Pharmacy 2004 39 1 Bach DS, Rissanen AM, Mendel CM, Shepherd G, Weinstein SP, Kelly F, Seaton TB, Patel B, Pekkarinen TA, Armstrong F. Absence of cardiac valve dysfunction in obese patients treated with sibutramine. Obesity Research 1999 7 363-9. Bandisode 1975 published data...

Comparison Drug therapy versus placebo for Fluoxetine FT fixed model random mode wks rho

Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Fixed 95 CI Weighted Mean Difference Random 95 CI Weighted Mean Difference Random 95 CI Weighted Mean Difference Random 95 CI Weighted Mean Difference Random 95 CI Weighted Mean Difference Random 95 CI Weighted Mean Difference Random 95 CI Weighted...

Random model rho Outcome BMI

Review Pharmacotherapy forwelght loss in adults with type 2 diabetes mellitus Comparison 18 Drug therapy versus placebo for Orlistat FT 1-13, fixed model 14-26, random model. rho 0.75 Outcome 17 BMI Mean Difference Random Weight Weighted Mean Difference Random N Mean SD N Mean SD 95 CI 95 CI Mean Difference Random Weight Weighted Mean Difference Random N Mean SD N Mean SD 95 CI 95 CI Test for heterogeneity chi-square 0.69 df Test for overall effect z l.7l p 0.09 -10.0 -5.0 0 5.0 10.0 Favours...